KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Treasury Shares: 2016-2023

Historic Treasury Shares for Moderna (MRNA) over the last 8 years, with Dec 2023 value amounting to $8.0 million.

  • Moderna's Treasury Shares fell 65.22% to $8.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $8.0 million, marking a year-over-year decrease of 65.22%. This contributed to the annual value of $8.0 million for FY2023, which is 65.22% down from last year.
  • According to the latest figures from FY2023, Moderna's Treasury Shares is $8.0 million, which was down 65.22% from $23.0 million recorded in FY2022.
  • In the past 5 years, Moderna's Treasury Shares registered a high of $23.0 million during FY2022, and its lowest value of $1.2 million during FY2019.
  • Moreover, its 3-year median value for Treasury Shares was $8.0 million (2023), whereas its average is $11.3 million.
  • Per our database at Business Quant, Moderna's Treasury Shares soared by 666.67% in 2022 and then tumbled by 65.22% in 2023.
  • Moderna's Treasury Shares (Yearly) stood at $1.2 million in 2019, then skyrocketed by 86.03% to $2.2 million in 2020, then soared by 36.99% to $3.0 million in 2021, then skyrocketed by 666.67% to $23.0 million in 2022, then crashed by 65.22% to $8.0 million in 2023.